Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Prognostic value of PLA2R autoimmunity detected by measurement of anti-PLA2R antibodies combined with detection of PLA2R antigen in membranous nephropathy: A single-centre study over 14 years.

Pourcine F, Dahan K, Mihout F, Cachanado M, Brocheriou I, Debiec H, Ronco P.

PLoS One. 2017 Mar 3;12(3):e0173201. doi: 10.1371/journal.pone.0173201. eCollection 2017.

2.

Anti-PLA2R Antibodies in Chinese Patients with Membranous Nephropathy.

Li X, Wei D, Zhou Z, Wang B, Xu Y, Pan J, Yang C, Lu J, Qiu Y.

Med Sci Monit. 2016 May 15;22:1630-6.

4.

Circulating Antibodies against Thrombospondin Type-I Domain-Containing 7A in Chinese Patients with Idiopathic Membranous Nephropathy.

Wang J, Cui Z, Lu J, Probst C, Zhang YM, Wang X, Qu Z, Wang F, Meng LQ, Cheng XY, Liu G, Debiec H, Ronco P, Zhao MH.

Clin J Am Soc Nephrol. 2017 Oct 6;12(10):1642-1651. doi: 10.2215/CJN.01460217. Epub 2017 Aug 11.

5.

Spontaneous remission of proteinuria is a frequent event in phospholipase A2 receptor antibody-negative patients with membranous nephropathy.

Hoxha E, Harendza S, Pinnschmidt HO, Tomas NM, Helmchen U, Panzer U, Stahl RA.

Nephrol Dial Transplant. 2015 Nov;30(11):1862-9. doi: 10.1093/ndt/gfv228. Epub 2015 Jul 3.

PMID:
26142398
6.

Membranous Nephropathy and Anti-Podocytes Antibodies: Implications for the Diagnostic Workup and Disease Management.

Pozdzik A, Brochériou I, David C, Touzani F, Goujon JM, Wissing KM.

Biomed Res Int. 2018 Jan 8;2018:6281054. doi: 10.1155/2018/6281054. eCollection 2018. Review.

7.

Primary Membranous Nephropathy.

Couser WG.

Clin J Am Soc Nephrol. 2017 Jun 7;12(6):983-997. doi: 10.2215/CJN.11761116. Epub 2017 May 26. Review. Erratum in: Clin J Am Soc Nephrol. 2017 Sep 7;12 (9):1528.

8.

Association of anti-phospholipasea2-receptor antibodies with clinical course of idiopathic membranous nephropathy.

Thokhonelidze I, Maglakelidze N, Sarishvili N, Kasradze T, Dalakishvili K.

Georgian Med News. 2015 Apr;(241):49-53.

PMID:
25953939
9.

Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy.

Hoxha E, Thiele I, Zahner G, Panzer U, Harendza S, Stahl RA.

J Am Soc Nephrol. 2014 Jun;25(6):1357-66. doi: 10.1681/ASN.2013040430. Epub 2014 Mar 7.

10.

Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy.

Ruggenenti P, Debiec H, Ruggiero B, Chianca A, Pellé T, Gaspari F, Suardi F, Gagliardini E, Orisio S, Benigni A, Ronco P, Remuzzi G.

J Am Soc Nephrol. 2015 Oct;26(10):2545-58. doi: 10.1681/ASN.2014070640. Epub 2015 Mar 24.

11.

PLA2R antibody levels and clinical outcome in patients with membranous nephropathy and non-nephrotic range proteinuria under treatment with inhibitors of the renin-angiotensin system.

Hoxha E, Harendza S, Pinnschmidt H, Panzer U, Stahl RA.

PLoS One. 2014 Oct 14;9(10):e110681. doi: 10.1371/journal.pone.0110681. eCollection 2014.

12.

Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy.

Hoxha E, Kneißler U, Stege G, Zahner G, Thiele I, Panzer U, Harendza S, Helmchen UM, Stahl RA.

Kidney Int. 2012 Oct;82(7):797-804. doi: 10.1038/ki.2012.209. Epub 2012 Jun 6.

13.

Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy.

Svobodova B, Honsova E, Ronco P, Tesar V, Debiec H.

Nephrol Dial Transplant. 2013 Jul;28(7):1839-44. doi: 10.1093/ndt/gfs439. Epub 2012 Dec 6.

PMID:
23223223
14.

[The relationship between anti-phospholipase A2 receptor antibody and idiopathic membranous nephropathy].

Lin W, Li H, Li X, Qin Y, Su Y, Yu Y, Guan Y, Duan L, Li Y, Wen Y, Li X.

Zhonghua Nei Ke Za Zhi. 2015 Sep;54(9):783-8. Chinese.

PMID:
26674797
15.

Biomarkers to detect membranous nephropathy in Chinese patients.

Lin L, Wang WM, Pan XX, Xu J, Gao CN, Zhang W, Ren H, Xie JY, Shen PY, Xu YW, Ni LY, Chen N.

Oncotarget. 2016 Oct 18;7(42):67868-67879. doi: 10.18632/oncotarget.12014.

16.

Anti-Phospholipase A2 Receptor (PLA2R) Antibody and Glomerular PLA2R Expression in Japanese Patients with Membranous Nephropathy.

Hihara K, Iyoda M, Tachibana S, Iseri K, Saito T, Yamamoto Y, Suzuki T, Wada Y, Matsumoto K, Shibata T.

PLoS One. 2016 Jun 29;11(6):e0158154. doi: 10.1371/journal.pone.0158154. eCollection 2016.

17.

Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy.

Oh YJ, Yang SH, Kim DK, Kang SW, Kim YS.

PLoS One. 2013 Apr 26;8(4):e62151. doi: 10.1371/journal.pone.0062151. Print 2013.

18.

Association of anti-PLA₂R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy.

Bech AP, Hofstra JM, Brenchley PE, Wetzels JF.

Clin J Am Soc Nephrol. 2014 Aug 7;9(8):1386-92. doi: 10.2215/CJN.10471013. Epub 2014 Jul 17.

19.

Anti-Phospholipase A2 Receptor Antibody as Prognostic Indicator in Idiopathic Membranous Nephropathy.

Kim YG, Choi YW, Kim SY, Moon JY, Ihm CG, Lee TW, Jeong KH, Yang SH, Kim YS, Oh YJ, Lee SH.

Am J Nephrol. 2015;42(3):250-7. doi: 10.1159/000440983. Epub 2015 Oct 20.

PMID:
26484659
20.

Clinical usefulness of autoantibodies to M-type phospholipase A2 receptor (PLA2R) for monitoring disease activity in idiopathic membranous nephropathy (IMN).

Radice A, Trezzi B, Maggiore U, Pregnolato F, Stellato T, Napodano P, Rolla D, Pesce G, D'Amico M, Santoro D, Londrino F, Ravera F, Ortisi G, Sinico RA.

Autoimmun Rev. 2016 Feb;15(2):146-54. doi: 10.1016/j.autrev.2015.10.004. Epub 2015 Oct 23. Review.

PMID:
26527329

Supplemental Content

Support Center